Not investment advice. Educational platform. See Disclaimer.
NASDAQ: ICLR
ICON Public Limited Company
Healthcare | Medical - Diagnostics & Research
No licensed closing price on file for ICLR. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.
EPS (FY2025)$2.90
ICON Public Limited Company (NASDAQ: ICLR) is a diagnostics and research company. Figures from SEC EDGAR; updated 2026-10-20 05:59 UTC.
What ICON Public Limited Company does
ICON plc is a contract research organization founded in Dublin, Ireland that provides outsourced development and services to pharmaceutical, biotechnology, medical device, and government organizations. The company offers clinical development services across all development phases, laboratory testing services including bio-analytical and vaccine testing, and full-service and functional service partnerships to customers.
Summarized from ICON Public Limited Company’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗
ICON plc is a contract research organization founded in Dublin, Ireland that provides outsourced development and services to pharmaceutical, biotechnology, medical device, and government organizations.
When did ICLR last file with the SEC?
ICON Public Limited Company's most recent SEC filing on record is a 6-K filed 2026-10-08. All filings link to their SEC EDGAR originals above.
Where does this data come from?
SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-20 05:59 UTC. This page is also available as JSON at /api/data?ticker=ICLR and is emitted with FAQPage structured data for machine reading.
For you
Charts, 10-year financials, peer comparison, screening and portfolio tracking for ICLR and 5,000+ tickers.